Sit Investment Associates Inc. reduced its stake in shares of Phibro Animal Health Corp (NASDAQ:PAHC) by 9.0% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 71,200 shares of the company’s stock after selling 7,000 shares during the period. Sit Investment Associates Inc.’s holdings in Phibro Animal Health were worth $2,385,000 as of its most recent filing with the SEC.
A number of other hedge funds also recently made changes to their positions in PAHC. Victory Capital Management Inc. raised its holdings in Phibro Animal Health by 17.6% during the 2nd quarter. Victory Capital Management Inc. now owns 5,380 shares of the company’s stock worth $199,000 after buying an additional 807 shares during the period. Capital Fund Management S.A. acquired a new stake in Phibro Animal Health during the 2nd quarter worth approximately $210,000. Susquehanna International Group LLP acquired a new stake in Phibro Animal Health during the 2nd quarter worth approximately $219,000. BNP Paribas Arbitrage SA raised its holdings in Phibro Animal Health by 55.7% during the 2nd quarter. BNP Paribas Arbitrage SA now owns 5,933 shares of the company’s stock worth $220,000 after buying an additional 2,123 shares during the period. Finally, Municipal Employees Retirement System of Michigan raised its holdings in Phibro Animal Health by 65.9% during the 3rd quarter. Municipal Employees Retirement System of Michigan now owns 7,250 shares of the company’s stock worth $269,000 after buying an additional 2,880 shares during the period. Hedge funds and other institutional investors own 48.42% of the company’s stock.
Shares of Phibro Animal Health Corp (NASDAQ:PAHC) opened at $35.70 on Friday. The company has a quick ratio of 1.85, a current ratio of 3.26 and a debt-to-equity ratio of 1.91. Phibro Animal Health Corp has a fifty-two week low of $26.10 and a fifty-two week high of $40.25. The stock has a market cap of $1,434.53, a P/E ratio of 23.33, a PEG ratio of 4.17 and a beta of 1.27.
Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings data on Monday, November 6th. The company reported $0.38 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.37 by $0.01. Phibro Animal Health had a net margin of 8.87% and a return on equity of 42.75%. The company had revenue of $193.40 million for the quarter, compared to the consensus estimate of $189.89 million. During the same period last year, the company earned $0.36 earnings per share. The firm’s revenue was up 2.9% compared to the same quarter last year. sell-side analysts predict that Phibro Animal Health Corp will post 1.57 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, December 27th. Stockholders of record on Wednesday, December 6th were issued a $0.10 dividend. The ex-dividend date was Tuesday, December 5th. This represents a $0.40 dividend on an annualized basis and a dividend yield of 1.12%. Phibro Animal Health’s dividend payout ratio (DPR) is presently 23.53%.
A number of analysts have recently issued reports on PAHC shares. BidaskClub downgraded shares of Phibro Animal Health from a “sell” rating to a “strong sell” rating in a report on Tuesday, December 12th. Piper Jaffray Companies reiterated a “buy” rating and issued a $42.00 price objective on shares of Phibro Animal Health in a report on Friday, November 10th. ValuEngine downgraded shares of Phibro Animal Health from a “buy” rating to a “hold” rating in a report on Thursday, November 9th. Finally, Zacks Investment Research downgraded shares of Phibro Animal Health from a “hold” rating to a “sell” rating in a report on Wednesday, November 8th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and two have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average target price of $38.25.
COPYRIGHT VIOLATION NOTICE: This piece of content was originally reported by Stock Observer and is the sole property of of Stock Observer. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of United States & international copyright legislation. The legal version of this piece of content can be read at https://www.thestockobserver.com/2018/01/14/phibro-animal-health-corp-pahc-shares-sold-by-sit-investment-associates-inc.html.
About Phibro Animal Health
Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.
Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Corp (NASDAQ:PAHC).
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.